Cardiovascular co-morbidity in patients with COPD in Bulgaria-Reference-Cited by-同舟云学术

Cardiovascular co-morbidity in patients with COPD in Bulgaria

Published:2020-01-01 Issue:1 Volume:34 Page:918-924
ISSN:1310-2818
Container-title:Biotechnology & Biotechnological Equipment
language:en
Short-container-title:Biotechnology & Biotechnological Equipment

Author:

Dimitrova Maria¹,Kamusheva Maria¹^ORCID,Tachkov Konstantin¹^ORCID,Mitov Konstantin¹,Doneva Miglena¹,Pencheva Ventsislava²,Petrova Daniela²^ORCID,Georgiev Ognyan²,Stoitchkov Jordan³,Petrova Guenka¹

Affiliation:

1. Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria

2. Department of Propaedeutic of Internal Diseases, UMHAT Alexandrovska, Medical University of Sofia, Sofia, Bulgaria

3. National Cardiology Hospital EAD, Sofia, Bulgaria

Publisher

Informa UK Limited

Subject

Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/13102818.2020.1810591

Reference37 articles.

1. GOLD 2019. [cited 2019 May]. Available from: http://goldcopd.org/wp-content/uploads/2017/11/GOLD-2010-v6.0-FINAL-revised-20-Nov_WMS.pdf.

2. Reducing mortality for chronic obstructive pulmonary disease: role of statins and angiotensin-converting enzyme inhibitors

3. Patterns of Comorbidities in Newly Diagnosed COPD and Asthma in Primary Care

4. Complex chronic comorbidities of COPD

5. Cardiovascular Comorbidities in Chronic Obstructive Pulmonary Disease (COPD)—Current Considerations for Clinical Practice

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Manifestations of COPD and the Impact of Dual Bronchodilation with Tiotropium/Olodaterol on Cardiac Function and Autonomic Integrity;Journal of Clinical Medicine;2024-05-16

2. Economic evaluations of chronic obstructive pulmonary disease pharmacotherapy: how well are the real-world issues of medication adherence, comorbidities and adverse drug-reactions addressed?;Expert Opinion on Pharmacotherapy;2021-01-13